Miglitol or Glyset is used in the treatment of diabetes, specifically type 2 diabetes or non insulin dependent diabetes.
Miglitol or Glyset interferes with the absorption of carbohydrates and thus reduces the rise in blood sugar levels. It needs to be taken at the beginning of a meal to have the most effect.
Miglitol or Glyset is associated with gastro intestinal side effects - flatulence, diarrhea, abdominal discomfort. It is recommended start with a lower dose and slowly increase to minimize these gastro intestinal side effects.
People with diabetes may find Miglitol or Glyset a useful addition to their drug regime, however, regular monitoring of blood glucose levels is still required.
With other drugs that also reduce blood sugar levels, Miglitol or Glyset has the potential to lower them too far, that is produce hypoglycemia. If hypoglycemia does occur, glucose not sucrose is needed to reverse the effect - Miglitol or Glyset will prevent the absorption of sucrose.
Diabetes Care 1998;21:409
The relevant product monographs must be regarded as the appropriate sources of prescribing information.